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Randomized clinical trials represent the gold standard of the evidence based medicine
research; nevertheless they may not always be feasible or ethical and the researchers have
to rely on observational studies or research databases. However, obtaining reliable results
from these studies requires the elimination of potential inﬂuence of confounding factors.
Fortunately, several statistical methods capable of identifying and reducing the impact of
confounding factors exist. One of them is the propensity score which has been frequently
used in recent times to estimate relevant clinical effects adjusted for given confounders.
This work aims to provide a concise and practical guide to propensity scores by means of
an easily understandable case study. The case study is focused on gender differences in
mortality rates of patients with acute heart failure in the Czech research database AHEAD
(Acute Heart Failure Database).
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. IntroductionEvidence based medicine (EBM) should be the principal
methodical approach and keystone of the current clinical
research and practice; it plays a key role in assessing strength
of the evidence of beneﬁts and risks of therapies as well as
diagnostic tests [1]. In order to obtain unbiased statistical
results, factors responsible for the causal effects have to bech Society of Cardiology.
63.
. Littnerova).distinguished from variables which show only a random
correlation with the study endpoint [2,3].
Randomized clinical trials are generally considered as the
gold standard for EBM. The initial randomization in such
trials increases the chance that the effect of treatment on
evaluated endpoint is given by treatment itself because the
other inﬂuencing factors (such as age and gender structure,
comorbidities, etc.) are randomly distributed between the
compared groups of patients. Unfortunately, these studiesPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved..
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 3 8 3 – e 3 9 0e384may not always be feasible/ethical or applicable for real life
situations in clinical practice [2].
In these situations, the observational studies can provide
sufﬁcient evidence; their advantage – as compared to the
randomized clinical trials – is the ability to capture the real
health care practice and to bring results which can be
extrapolated on the population level. However, obtaining
sufﬁciently unbiased results from these studies requires
sophisticated statistical methods because the prerequisite
of a random distribution of inﬂuential factors other than
treatment itself is not always fulﬁlled and, therefore, the
treatment effect is not independent of confounding factors
[3,4].
Nowadays, several statistical methods working effectively
with multiple mutually correlated variables exist. One of
these methods is the propensity score method introduced
in 1983 by Rosenbaum and Rubin, who deﬁned the score as a
“conditional probability of assignment to a particular treat-
ment on a given vector of observed covariates” [5]. In other
words, the score represents the patients' probability of
belonging to the same comparable population based on their
descriptive characteristics, i.e. confounding factors. The main
aim of this method is to obtain an unbiased estimate of
treatment effect adjusted for the impact of given confounding
factors in non-randomized and observational studies [3,4,6].
Due to its properties, the propensity score has recently
become a widely used method in a broad range of epidemio-
logical studies; its usage increased from 294 publications in
the years 1998–2002 to 1111 in 2003–2007 and 3539 in 2008–
2012.
Although several papers describe the methodology of the
propensity score in detail [4,6], provide an example analysis
on simulated data [7] or a systematic literature review [8,9],
only few give examples of the application of propensity score
on real data. The aim of this work is to explain the principles
and advantages of the propensity score for clinical research-
ers. In addition to the theoretical background of the propen-
sity score calculation, an analysis of inﬂuence of gender
differences on mortality in acute heart failure patients is
used as an educational case study (based on the Acute Heart
Failure Database—AHEAD 2006–09 [10,11]).2. Propensity score
The advantage of propensity score in comparison to multi-
variable adjustment is the separation of confounding factors
adjustment and analysis of the treatment effect steps [6].
Rosenbaum and Rubin [5] deﬁned the propensity score for a
patient as the conditional probability of being treated
(exposed) given the vector of observed covariates. Let us
assume that observed covariates X¼ (X1, X2,…,Xn) and an
indicator of treatment group Z (Z¼1 if treated and Z¼0 if
control) are assigned to each patient. The propensity score,
denoted here as PS, is deﬁned for each patient as the
probability that she/he received the treatment (Z¼1), given
his/her observed covariates PS¼P(Z¼1|X). The probability in
each patient of being either treated or untreated ranges from
0 to 1, i.e. 0oPSo1. The theory of propensity score relies on
two major assumptions: (1) the observed variables do notaffect the clinician's decision that a patient will be treated (for
example, gender/age of patients does not inﬂuence the
administration of treatment) and (2) there are no unmea-
sured confounders (all the covariates potentially related to
treatment assignment are known).
In an observational study, covariates are usually not
balanced between treatment groups. Rosenbaum and Rubin
[5] have demonstrated that observed covariates are balanced
at each value of propensity score; it means that patients in
treated and control groups with equal propensity score have
the same distributions of the observed covariates.
The propensity score can be understood as a proxy
between cases and covariates inﬂuencing the exposure, so
it can be used instead of additional analyses of the covariates
to simplify the analysis. Therefore, the propensity score as a
proxy variable aggregates multiple confounding factors into a
single dimension [4,5].
The simplest approach to estimate the propensity score is
a simple tabular analysis where for each input variable it is
obtained from a ratio of patients with and without treatment
(Fig. 1); nevertheless, this approach is not suitable for con-
tinuous variables. To solve this problem, there are a plenty of
other parametric and non-parametric methods for estimating
the propensity score. For example, D'Agostino used the
discrimination analysis to estimate the propensity score,
while McCaffrey et al. published a paper where generalized
boosted models were used to compute the propensity score
[12]; Setouguchi et al. published a simulation study where
neural networks and classiﬁcation trees were adopted to
estimate the propensity score. Nevertheless, these methods
have major disadvantages such as their complexity and
problems with subsequent interpretations, and their use is
associated with considerable complications as a result of
complex algorithms and their implementations [12]. For
these reasons, the logistic regression has become the most
frequently used technique to estimate the propensity score
[4,9,13] and it was also used in our work.
Logistic regression is a statistical technique which esti-
mates the probability of an event (the dependent variable)
based on known factors (independent variables) which are
expected to affect the occurrence of the event (treatment in
the case of propensity score computation). The dependent
variable can therefore only assume two values depending on
whether the event (treatment) occurred or not. The result of
logistic regression is the probability (ranging from 0 to 1) of an
event occurring according to values of independent variables.
Furthermore, logistic regression is a known and relatively
easily understandable method for most researchers and it is
implemented in all basic statistical software (SPSS, Stata,
Statistica, SAS, R, etc.) [13].
The results of logistic regression can then be used to
calculate the propensity score according to the following
formula:
PS¼ PðZ¼ 1jXÞ ¼ exp ðβ0 þ β1x1 þ β2x2 þ…þ βnxnÞ
1þexp ðβ0 þ β1x1 þ β2x2 þ…þ βnxnÞ;
where x1, x2 to xn are independent covariates (in the example
in Fig. 2a these are gender and age), β0, β1 to βn are the
corresponding regression coefﬁcients, coefﬁcient β0
Fig. 1 – Propensity score computation using the contingency table.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 3 8 3 – e 3 9 0 e385represents the inﬂuence of an absolute component (the value
of the probability when all covariates are equal to zero).
Parameters β0, β1 to βn are estimated from the data using the
maximum likelihood method [14] as shown in Fig. 2(a). After
obtaining the propensity score, it is used to derive a pseudo-
randomized dataset, allowing an unbiased estimation of the
exposure (treatment) effect.3. Application of propensity score for bias
adjustment
The main and the most common approach of propensity
score usage is prior to the quantiﬁcation of treatment effect
for data-matching; that is also described in our text. Other
theoretical approaches (such as stratiﬁcation and adjust-
ment) were also developed but these are used less frequently
[4,5,9,13].
Matching is a technique which creates a balanced dataset
by making pairs from control and treated patients on the
basis of a similar value of their propensity score; however, its
major disadvantage is the fact that some patients may be
discarded from the dataset. The matching method consists of
selecting the ﬁrst treated patient and ﬁnding the control
patient with the same or nearly the same propensity score
(Fig. 2b). To avoid matching of patients with largely different
propensity scores, calliper is used to ensure that matching
can only occur within a given range of propensity score
values. This procedure may result in the situation when we
have unpaired patients who are excluded from the subse-
quent analyses.
The efﬁcacy of a propensity score model is estimated by
the absolute standardized difference in individual covariates
between groups of patients after matching. An absolute
standardized difference 0% of a covariate indicates no resi-
dual bias for that covariate and an absolute standardized
difference below 10% means an insigniﬁcant residual bias
[15].Matching based on the propensity score is frequently used
in medical literature [8,9,16]. Several reasons contribute to the
popularity of propensity score matching; matching can elim-
inate a greater portion of bias when estimating the more
precise treatment effect as compared to other approaches
[17]; matching by the propensity score creates a balanced
dataset, allowing a simple and direct comparison of baseline
covariates between treated and untreated patients. For these
reasons, we have selected a case study of matching based on
propensity score as a practical example of its most common
usage. On the other hand, we should not forget that the
balanced dataset obtained by matching does not contain all
patients, and, therefore some information about the original
dataset structure is lost.3.1. Case study on the application of the propensity score
in the acute heart failure mortality study (project AHEAD
2006–2009)
The following text explains how the propensity score works.
In this example, we have chosen gender differences and their
inﬂuence on mortality of patients. It is known that in
population with heart failure men are younger than women
and women have lower mortality rates than men [18–21]. The
application of the propensity score allows us to obtain a
balanced dataset and a more precise estimate of gender
differences in mortality of patients (study endpoint). In this
case study, gender represents the treatment indicator intro-
duced in the theoretical part of this paper (Z¼1 if male and
Z¼0 if female).
Data analyzed in this example came from the research
database of acute heart failure AHEAD Main. The database
AHEAD Main includes consecutive patients from seven cen-
ters with a 24-hour Catheterization Laboratory service and a
centralized care for patients with acute coronary syndromes
(ACS) from a region of about three million inhabitants [10,11].
The entire dataset contained 4153 patients, with 1757 (42.3%)
women and 2396 (57.7%) men. In agreement with literature
Fig. 2 – (a) Propensity score computation using the logistic regression and (b) propensity score matching.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 3 8 3 – e 3 9 0e386[18–21], our results have conﬁrmed that men with acute heart
failure are younger than women with that condition (Fig. 3,
Table 1).Moreover, men were also different from women in several
other parameters (Table 1). The above-described propensity
score methodology was applied on this primary dataset. Prior
Fig. 3 – Distribution of age in men and women, before and after propensity score matching; the distribution of age is the
same after matching.
Table 1 – Observed covariates before and after matching.
n (%)/median (5th; 95th
percentile)
Before matching After matching
Women
N¼1757
Men N¼2396 pa Women
N¼1128
Men N¼1128 pa
Ageb 78 (55; 90) 69 (46; 86) o0.001 75 (52; 87) 75 (54; 87) 0.917
BMI 27.6 (20.3; 38.3) 27.7 (21.6; 37.8) 0.056 27.7 (20.5; 38.3) 27.7 (22.1; 37.5) 0.621
Systolic BP 140 (85; 210) 130 (80; 200) o0.001 140 (90; 210) 140 (90; 200) 0.050
Diastolic BP 80 (50; 110) 80 (50; 110) 0.551 80 (50; 113) 80 (55; 110) 0.180
Heart rate 89 (50; 145) 90 (55; 140) 0.154 90 (55; 145) 90 (55; 140) 0.209
Ejection fractionb 42 (20; 65) 35 (15; 62) o0.001 40 (20; 65) 40 (18; 65) 0.367
Creatinine clearanceb 46.8 (18.6; 83.1) 54.2 (22.0; 91.8) o0.001 49.7 (21.9; 86.8) 50.5 (21.1; 84.8) 0.824
AHF
De-novo 1049 (60.9%) 1320 (56.4%) 0.004 683 (60.5%) 558 (49.5%) o0.001
ACS 585 (33.3%) 888 (37.1%) 0.013 400 (35.5%) 396 (35.1%) 0.860
AHF syndromes
ADHF 905 (51.5%) 1335 (55.7%) 0.008 620 (55.0%) 668 (59.2%) 0.051
Pulmonary edema 330 (18.8%) 418 (17.4%) 0.265 220 (19.5%) 200 (17.7%) 0.279
Cardiogenic shock 234 (13.3%) 366 (15.3%) 0.077 132 (11.7%) 128 (11.3%) 0.792
NYHA
I 367 (20.9%) 585 (24.4%) o0.001 263 (23.3%) 259 (23.0%) 0.213
II 569 (32.4%) 629 (26.3%) 375 (33.2%) 316 (28.0%)
III 541 (30.8%) 757 (31.6%) 364 (32.3%) 422 (37.4%)
IV 184 (10.5%) 271 (11.3%) 126 (11.2%) 131 (11.6%)
Medical history
Hypertension 1306 (78.2%) 1569 (69.3%) o0.001 859 (76.4%) 849 (75.3%) 0.546
Diabetes mellitusb 774 (46.2%) 902 (39.8%) o0.001 507 (44.9%) 516 (45.7%) 0.703
Myocardial infarctionb 448 (26.7%) 815 (36.0%) o0.001 344 (30.5%) 340 (30.1%) 0.855
PCI and CABG 7 (0.4%) 14 (0.6%) 0.399 5 (0.4%) 7 (0.6%) 0.562
Stroke or TIA 302 (18.0%) 351 (15.5%) 0.038 186 (16.5%) 189 (16.8%) 0.865
Fibrillation or flutter 489 (27.8%) 593 (24.7%) 0.025 299 (26.5%) 337 (29.9%) 0.075
BP—Blood pressure, ACS—acute coronary syndrome, ADHF—acute decompensated heart failure, MI—myocardial infarction, PCI—percuta-
neous coronary intervention; CABG—coronary artery bypass graft, TIA—transient ischemic attack.
a Statistical signiﬁcance of difference between men and women, continuous parameters were tested by Mann–Whitney U test, categorical by
ML Chi-square test.
b Parameters included in the propensity score model.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 3 8 3 – e 3 9 0 e387to the computation of a propensity score using the logistic
regression (as in example in Fig. 2a), we had to choose
covariates which differ between genders and could representconfounding factors for the analyzed endpoint. The ﬁrst step
of variable selection consisted of the identiﬁcation of impor-
tant input variables both inﬂuencing mortality and
Fig. 4 – Absolute standardized differences (%) in observed
covariates between men and women before and after
propensity score matching (based on age, ejection fraction,
diabetes mellitus, myocardial infarction in medical history,
creatinine clearance at admission); the covariates with
postmatch absolute standardized differences below 10% are
considered as successfully balanced.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 3 8 3 – e 3 9 0e388discriminating genders; it was based on the combination of
results from data analysis, expert knowledge, and published
results. All covariates shown in Table 1 were used in a
forward stepwise selection to select covariates which were
necessary to assemble the model. The ﬁnal propensity score
model consisted of four covariates: age, ejection fraction (EF),
diabetes mellitus (DM) and myocardial infarction (MI) in
medical history and creatinine clearance at admission (CC);
the ﬁnal regression equation was
PS¼ PðZ¼ 1 Age;EF;DM;MI;CCÞ ¼


exp ð3:94−0:04Age−0:03EF−0:18DMþ 0:47MIþ 0:01CCÞ
1þ exp ð3:94−0:04Age−0:03EF−0:18DMþ 0:47MIþ 0:01CCÞ :
The propensity score was then applied to match the
structure of confounding factors for women with that for
men, based on calliper 0.01 standard deviation of the
propensity score. The ﬁnal balanced dataset consisted of
2256 patients (54.3% of original dataset): 1128 (50%) men
and 1128 (50%) women. The decrease in the number of
patients in the balanced dataset resulted in a shifted age
structure; in total, patients in the balanced dataset were older
than in the original dataset and the results obtained from the
analyses of balanced dataset should be interpreted only for
these older patients (Fig. 3).
The ability of propensity score to effectively balance the
groups according to input variables was conﬁrmed by com-
bining the results in Table 1 and in Fig. 4. Table 1 shows that
almost all covariates that entered the propensity score model
were no longer signiﬁcant in the matched sample. The
absolute standardized differences of covariates between both
genders after matching are shown in Fig. 4. The remaining
covariates that signiﬁcantly differed between genders
(Table 1, Fig. 4) were due to the limited complexity of the
propensity score model. Models with more covariates are
better balanced but result in a smaller ﬁnal dataset and so are
less representative of the original dataset.
De-novo acute heart failure as the remaining signiﬁcant
covariate had only a limited inﬂuence on the outcome (its
relationship with mortality was statistically non-signiﬁcant).
We have effectively balanced the dataset on age, DM, CC, EF,
and previous MI in medical history. These factors differed
between genders and are known as the most important in
relation to mortality [10,11].
The main aim of our analysis was the comparison of
men's and women's mortality rates. The difference in the
mortality rates between men and women was not statisti-
cally signiﬁcant in the original dataset (Fig. 5): the 5-year
mortality rates were 58.0% for men and 60.4% for women
(log-rank test p¼0.239). In the balanced dataset, however, the
5-year mortality rates were 63.1% for men and 56.8% for
women: this difference was statistically signiﬁcant (p¼0.002)
(Fig. 6). The same pattern was found in the Norwegian Heart
Failure Registry [20], where women had signiﬁcantly lower
mortality rates, too.4. Conclusion
Propensity score is nowadays widely used in statistical
analyses, particularly in the observational clinical studies. Itis likely that its use will increase because the rising avail-
ability of data collection in research databases makes the
observational design of studies more interesting and feasible
[13]. The main advantage of the propensity score methodol-
ogy is in its contribution to the more precise estimation of
treatment response. Thus, the propensity score could be
currently recommended as a standard tool for investigators
trying to estimate the effects of treatments in studies where
any potential bias may exist. Another promising application
of the propensity score in health care studies is in the ﬁeld of
health technology assessment in comparing different health
care facilities or health care providers. These units typically
operate over a very different case-mix and the propensity score
represents an effective approach to the extraction of mutually
comparable samples from the real-life clinical data [22].
The use of propensity score matching in our case study
revealed signiﬁcant differences in mortality rates between
both genders. This is due to the fact that the propensity
score-matched dataset was balanced with respect to selected
covariates; in other words, most of the bias inﬂuencing the
mortality was removed using the propensity score
Fig. 5 – Mortality rates after admission before matching
(original dataset) for men versus women in the clinical
database AHEAD. There was no statistically significant
difference between men and women (p¼0.239).
Fig. 6 – Mortality rates after admission after matching
(balanced dataset) for men versus women in the clinical
database AHEAD. A statistically significant difference was
found between men and women (p¼0.002).
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 3 8 3 – e 3 9 0 e389methodology. Thus, we obtained more correct estimates of
mortality rates for both genders.Funding
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